Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy.

Blessing MM, Blackburn PR, Balcom JR, Krishnan C, Harrod VL, Zimmermann MT, Barr Fritcher EG, Zysk CD, Jackson RA, Nair AA, Jenkins RB, Halling KC, Kipp BR, Ida CM.

Acta Neuropathol Commun. 2018 Nov 5;6(1):118. doi: 10.1186/s40478-018-0622-1. No abstract available.

2.

Activity of EGFR Antibody in Non-V600 BRAF Mutant Metastatic Colorectal Cancer.

Wang Y, Jones JC, Kipp BR, Grothey A.

Ann Oncol. 2018 Oct 26. doi: 10.1093/annonc/mdy477. [Epub ahead of print] No abstract available.

PMID:
30364934
3.

Sellar Region Atypical Teratoid/Rhabdoid Tumors in Adults: Clinicopathological Characterization of Five Cases and Review of the Literature.

Paolini MA, Kipp BR, Sukov WR, Jenkins SM, Barr Fritcher EG, Aranda D, SantaCruz KS, Al-Dandan S, Fisher P, McDonald WC, Bondurant CP, Van Dyke Darkow G, Giannini C, Parisi JE, Jentoft ME, Raghunathan A.

J Neuropathol Exp Neurol. 2018 Dec 1;77(12):1115-1121. doi: 10.1093/jnen/nly091.

PMID:
30295777
4.

Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.

Milosevic D, Mills JR, Campion MB, Vidal-Folch N, Voss JS, Halling KC, Highsmith WE, Liu MC, Kipp BR, Grebe SKG.

Clin Chem. 2018 Dec;64(12):1732-1742. doi: 10.1373/clinchem.2018.291278. Epub 2018 Sep 20.

PMID:
30237149
5.

Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors.

Winters JL, Davila JI, McDonald AM, Nair AA, Fadra N, Wehrs RN, Thomas BC, Balcom JR, Jin L, Wu X, Voss JS, Klee EW, Oliver GR, Graham RP, Neff JL, Rumilla KM, Aypar U, Kipp BR, Jenkins RB, Jen J, Halling KC.

J Mol Diagn. 2018 Jul;20(4):495-511. doi: 10.1016/j.jmoldx.2018.03.007. Epub 2018 Jun 19.

6.

Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas.

Levy MJ, Kipp BR, Milosevic D, Schneider AR, Voss JS, Avula R, Kerr SE, Henry MR, Highsmith E Jr, Liu MC, Gleeson FC.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1632-1640.e1. doi: 10.1016/j.cgh.2018.02.048. Epub 2018 Mar 8.

PMID:
29526691
7.

Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas.

Clay R, Kipp BR, Jenkins S, Karwoski RA, Maldonado F, Rajagopalan S, Voss JS, Bartholmai BJ, Aubry MC, Peikert T.

Sci Rep. 2017 Dec 15;7(1):17620. doi: 10.1038/s41598-017-17659-6.

8.

Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.

Gleeson FC, Voss JS, Kipp BR, Kerr SE, Van Arnam JS, Mills JR, Marcou CA, Schneider AR, Tu ZJ, Henry MR, Levy MJ.

Oncotarget. 2017 Jun 28;8(55):93464-93475. doi: 10.18632/oncotarget.18750. eCollection 2017 Nov 7.

9.

Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous Process.

Ida CM, Butz ML, Jenkins RB, Sarkaria JN, Kitange GJ, Giannini C, Kipp BR.

Am J Clin Pathol. 2017 Oct 1;148(4):296-307. doi: 10.1093/ajcp/aqx073.

PMID:
28967952
10.

Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience.

Johnson B, Jin Z, Truty MJ, Smoot RL, Nagorney DM, Kendrick ML, Kipp BR, Grothey A.

Oncologist. 2018 Jan;23(1):128-134. doi: 10.1634/theoncologist.2017-0230. Epub 2017 Sep 13.

PMID:
28904173
11.

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

Goetz MP, Suman VJ, Reid JM, Northfelt DW, Mahr MA, Ralya AT, Kuffel M, Buhrow SA, Safgren SL, McGovern RM, Black J, Dockter T, Haddad T, Erlichman C, Adjei AA, Visscher D, Chalmers ZR, Frampton G, Kipp BR, Liu MC, Hawse JR, Doroshow JH, Collins JM, Streicher H, Ames MM, Ingle JN.

J Clin Oncol. 2017 Oct 20;35(30):3391-3400. doi: 10.1200/JCO.2017.73.3246. Epub 2017 Aug 30.

12.

Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.

Boland JM, Maleszewski JJ, Wampfler JA, Voss JS, Kipp BR, Yang P, Yi ES.

Hum Pathol. 2018 Jan;71:8-19. doi: 10.1016/j.humpath.2017.08.002. Epub 2017 Aug 17.

PMID:
28823574
13.

Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA-related segmental overgrowth: Co-occurrence of mosaicism for 2 rare disorders.

Mills JR, Moyer AM, Kipp BR, Poplawski AB, Messiaen LM, Babovic-Vuksanovic D.

Clin Genet. 2018 Jan;93(1):187-190. doi: 10.1111/cge.13099. Epub 2017 Nov 29.

PMID:
28737257
14.

Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story.

Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, Johnson SH, Serla V, Ryu JH, Yi ES, Kipp BR, Vasmatzis G, Carmona EM.

Mod Pathol. 2017 Sep;30(9):1223-1233. doi: 10.1038/modpathol.2017.52. Epub 2017 Jun 23.

15.

Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism.

Vaubel RA, Kollmeyer TM, Caron AA, Barr Fritcher EG, Voss JS, Liang H, Jenkins RB, Giannini C, Kipp BR.

Acta Neuropathol. 2017 Aug;134(2):317-319. doi: 10.1007/s00401-017-1727-5. Epub 2017 May 26. No abstract available.

PMID:
28550371
16.

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.

Jones JC, Renfro LA, Al-Shamsi HO, Schrock AB, Rankin A, Zhang BY, Kasi PM, Voss JS, Leal AD, Sun J, Ross J, Ali SM, Hubbard JM, Kipp BR, McWilliams RR, Kopetz S, Wolff RA, Grothey A.

J Clin Oncol. 2017 Aug 10;35(23):2624-2630. doi: 10.1200/JCO.2016.71.4394. Epub 2017 May 9.

17.

Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.

Al-Shamsi HO, Jones J, Fahmawi Y, Dahbour I, Tabash A, Abdel-Wahab R, Abousamra AO, Shaw KR, Xiao L, Hassan MM, Kipp BR, Kopetz S, Soliman AS, McWilliams RR, Wolff RA.

J Gastrointest Oncol. 2016 Dec;7(6):882-902. doi: 10.21037/jgo.2016.11.02.

18.

Impact of RNA degradation on fusion detection by RNA-seq.

Davila JI, Fadra NM, Wang X, McDonald AM, Nair AA, Crusan BR, Wu X, Blommel JH, Jen J, Rumilla KM, Jenkins RB, Aypar U, Klee EW, Kipp BR, Halling KC.

BMC Genomics. 2016 Oct 20;17(1):814.

19.

Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.

Zhang BY, Jones JC, Briggler AM, Hubbard JM, Kipp BR, Sargent DJ, Dixon JG, Grothey A.

Clin Colorectal Cancer. 2017 Jun;16(2):124-128. doi: 10.1016/j.clcc.2016.09.003. Epub 2016 Sep 17.

PMID:
27726953
20.

Ciliated Muconodular Papillary Tumors of the Lung Can Occur in Western Patients and Show Mutations in BRAF and AKT1.

Liu L, Aesif SW, Kipp BR, Voss JS, Daniel S, Aubry MC, Boland JM.

Am J Surg Pathol. 2016 Dec;40(12):1631-1636.

PMID:
27454941
21.

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.

Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR.

Cancer Lett. 2016 Sep 28;380(1):163-73. doi: 10.1016/j.canlet.2016.05.017. Epub 2016 May 20.

22.

S768I Mutation in EGFR in Patients with Lung Cancer.

Leventakos K, Kipp BR, Rumilla KM, Winters JL, Yi ES, Mansfield AS.

J Thorac Oncol. 2016 Oct;11(10):1798-801. doi: 10.1016/j.jtho.2016.05.007. Epub 2016 May 20.

23.

Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.

Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, Henry MR, Graham RP, Vasmatzis G, Cheville JC, Lazaridis KN, Levy MJ.

Oncotarget. 2016 Aug 23;7(34):54526-54536. doi: 10.18632/oncotarget.9440.

24.

Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.

Terra SB, Jang JS, Bi L, Kipp BR, Jen J, Yi ES, Boland JM.

Mod Pathol. 2016 Aug;29(8):824-31. doi: 10.1038/modpathol.2016.89. Epub 2016 May 13.

25.

Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.

Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, Henry MR, Vasmatzis G, Cheville JC, Lazaridis KN, Levy MJ.

Gastrointest Endosc. 2016 Dec;84(6):950-958.e3. doi: 10.1016/j.gie.2016.04.027. Epub 2016 Apr 23.

PMID:
27118626
26.

Hepatocellular Neoplasms Arising in Association With Androgen Use.

Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T.

Am J Surg Pathol. 2016 Apr;40(4):454-61. doi: 10.1097/PAS.0000000000000576.

PMID:
26685086
27.

Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.

Chaiteerakij R, Barr Fritcher EG, Angsuwatcharakon P, Ridtitid W, Chaithongrat S, Leerapun A, Baron TH, Kipp BR, Henry MR, Halling KC, Rerknimitr R, Roberts LR.

Gastrointest Endosc. 2016 Jun;83(6):1228-35. doi: 10.1016/j.gie.2015.11.037. Epub 2015 Dec 10.

PMID:
26684604
28.

Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease.

Murphy SJ, Hart SN, Halling GC, Johnson SH, Smadbeck JB, Drucker T, Lima JF, Rohakhtar FR, Harris FR, Kosari F, Subramanian S, Petersen GM, Wiltshire TD, Kipp BR, Truty MJ, McWilliams RR, Couch FJ, Vasmatzis G.

Cancer Res. 2016 Feb 1;76(3):749-61. doi: 10.1158/0008-5472.CAN-15-2198. Epub 2015 Dec 16.

29.

Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.

Murphy SJ, Karnes RJ, Kosari F, Castellar BE, Kipp BR, Johnson SH, Terra S, Harris FR, Halling GC, Klein JL, Nasir A, Bergstrahl E, Rangel LJ, Sukov WR, Vasmatzis G, Cheville JC.

Mod Pathol. 2016 Feb;29(2):143-56. doi: 10.1038/modpathol.2015.136. Epub 2015 Nov 27.

30.

Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.

Yamada S, Kipp BR, Voss JS, Giannini C, Raghunathan A.

Am J Surg Pathol. 2016 Feb;40(2):279-84. doi: 10.1097/PAS.0000000000000515.

PMID:
26414224
31.

An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.

Barr Fritcher EG, Voss JS, Brankley SM, Campion MB, Jenkins SM, Keeney ME, Henry MR, Kerr SM, Chaiteerakij R, Pestova EV, Clayton AC, Zhang J, Roberts LR, Gores GJ, Halling KC, Kipp BR.

Gastroenterology. 2015 Dec;149(7):1813-1824.e1. doi: 10.1053/j.gastro.2015.08.046. Epub 2015 Aug 29.

PMID:
26327129
32.

FGFR1 and FGFR2 in fibrolamellar carcinoma.

Graham RP, Garcia JJ, Greipp PT, Barr Fritcher EG, Kipp BR, Torbenson MS.

Histopathology. 2016 Apr;68(5):686-92. doi: 10.1111/his.12799. Epub 2015 Oct 5.

PMID:
26259677
33.

Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma.

Yang JD, Campion MB, Liu MC, Chaiteerakij R, Giama NH, Ahmed Mohammed H, Zhang X, Hu C, Campion VL, Jen J, Venkatesh SK, Halling KC, Kipp BR, Roberts LR.

Hepatology. 2016 Jan;63(1):148-58. doi: 10.1002/hep.27944. Epub 2015 Aug 7.

34.

Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.

Brankley SM, Halling KC, Jenkins SM, Timmer MR, Iyer PG, Smyrk TC, Barr Fritcher EG, Voss JS, Kipp BR, Campion MB, Lutzke LS, Minot DM, Wang KK.

Dis Esophagus. 2016 Aug;29(6):513-9. doi: 10.1111/dote.12372. Epub 2015 Jun 5.

35.

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.

Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS.

BMC Cancer. 2015 May 19;15:415. doi: 10.1186/s12885-015-1421-8.

36.

Endoscopic ultrasound fine-needle aspiration cytology mutation profiling using targeted next-generation sequencing: personalized care for rectal cancer.

Gleeson FC, Kipp BR, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Sciallis AP, Graham RP, Lazaridis KN, Henry MR, Levy MJ.

Am J Clin Pathol. 2015 Jun;143(6):879-88. doi: 10.1309/AJCPU3J7FGAYQBRL.

PMID:
25972331
37.

Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential.

Gleeson FC, Kipp BR, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Graham RP, Lazaridis KN, Henry MR, Levy MJ.

Gastrointest Endosc. 2015 Sep;82(3):550-6.e1. doi: 10.1016/j.gie.2015.01.050. Epub 2015 Apr 14.

PMID:
25887718
38.

Somatic STK11 and concomitant STK11/KRAS mutational frequency in stage IV lung adenocarcinoma adrenal metastases.

Gleeson FC, Kipp BR, Levy MJ, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Lazaridis KN, Kerr SE.

J Thorac Oncol. 2015 Mar;10(3):531-4. doi: 10.1097/JTO.0000000000000391.

39.

Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.

Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, Famuyide AO, Clayton AC, Halling KC, Kerr SE, Cliby WA, Dowdy SC, Kipp BR, Mariani A, Oberg AL, Podratz KC, Shridhar V, Sherman ME.

Gynecol Oncol. 2015 Apr;137(1):14-22. doi: 10.1016/j.ygyno.2015.01.552. Epub 2015 Feb 10.

40.

Detection of circulating tumor cells in high-risk endometrial cancer.

Bogani G, Liu MC, Dowdy SC, Cliby WA, Kerr SE, Kalli KR, Kipp BR, Halling KC, Campion MB, Mariani A.

Anticancer Res. 2015 Feb;35(2):683-7.

PMID:
25667446
41.

High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case report.

Noriega-Iriondo MF, Colon-Otero G, Kipp BR, Copland JA, Ferber MJ, Marlow LA, Roberts ME, Robertson MW, Dinh TA, Attia S, Geiger XJ, Riegert-Johnson DL.

Hered Cancer Clin Pract. 2015 Jan 23;13(1):6. doi: 10.1186/s13053-015-0027-0. eCollection 2015.

42.

Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.

Eaton JE, Barr Fritcher EG, Gores GJ, Atkinson EJ, Tabibian JH, Topazian MD, Gossard AA, Halling KC, Kipp BR, Lazaridis KN.

Am J Gastroenterol. 2015 Feb;110(2):299-309. doi: 10.1038/ajg.2014.433. Epub 2015 Jan 27.

43.

Characterization of endoscopic ultrasound fine-needle aspiration cytology by targeted next-generation sequencing and theranostic potential.

Gleeson FC, Kipp BR, Kerr SE, Voss JS, Lazaridis KN, Katzka DA, Levy MJ.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):37-41. doi: 10.1016/j.cgh.2014.10.017. Epub 2014 Oct 24. Review.

PMID:
25424571
44.

Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.

Murphy SJ, Aubry MC, Harris FR, Halling GC, Johnson SH, Terra S, Drucker TM, Asiedu MK, Kipp BR, Yi ES, Peikert T, Yang P, Vasmatzis G, Wigle DA.

J Clin Oncol. 2014 Dec 20;32(36):4050-8. doi: 10.1200/JCO.2014.56.7644. Epub 2014 Nov 10.

45.

FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.

Barr Fritcher EG, Kipp BR, Halling KC, Clayton AC.

Cytopathology. 2014 Oct;25(5):288-301. doi: 10.1111/cyt.12170. Epub 2014 Jul 30. Review.

PMID:
25073411
46.

Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.

Gleeson FC, Kipp BR, Levy MJ, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Lazaridis KN, Kerr SE.

Cancer Cytopathol. 2014 Nov;122(11):822-32. doi: 10.1002/cncy.21464. Epub 2014 Jul 15.

47.

Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.

Kerr SE, Barr Fritcher EG, Campion MB, Voss JS, Kipp BR, Halling KC, Lewis JT.

Hum Pathol. 2014 Sep;45(9):1797-804. doi: 10.1016/j.humpath.2014.05.008. Epub 2014 Jun 4.

PMID:
25027853
48.

Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing.

Gleeson FC, Kipp BR, Kerr SE, Voss JS, Graham RP, Campion MB, Minot DM, Tu ZJ, Klee EW, Lazaridis KN, Henry MR, Levy MJ.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):202-6. doi: 10.1016/j.cgh.2014.06.024. Epub 2014 Jul 3.

PMID:
24997326
49.

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.

Graham RP, Barr Fritcher EG, Pestova E, Schulz J, Sitailo LA, Vasmatzis G, Murphy SJ, McWilliams RR, Hart SN, Halling KC, Roberts LR, Gores GJ, Couch FJ, Zhang L, Borad MJ, Kipp BR.

Hum Pathol. 2014 Aug;45(8):1630-8. doi: 10.1016/j.humpath.2014.03.014. Epub 2014 Apr 13.

PMID:
24837095
50.

PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors.

Maleszewski JJ, Larsen BT, Kip NS, Castonguay MC, Edwards WD, Carney JA, Kipp BR.

Am J Surg Pathol. 2014 Aug;38(8):1079-87. doi: 10.1097/PAS.0000000000000202.

PMID:
24618615

Supplemental Content

Support Center